Goldiam International (526729) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
20 Oct, 2026Executive summary
Q3 consolidated revenue from operations was Rs 27,962.60 lakh and net profit was Rs 4,975.97 lakh, versus Rs 20,182.04 lakh and Rs 3,239.23 lakh a year earlier.
9M consolidated revenue was Rs 58,240.77 lakh and net profit was Rs 9,392.73 lakh.
Lab-grown diamond jewellery made up 80% of Q3 export revenue, compared with 58% a year earlier.
Limited review reports found no matter indicating material misstatement or non-compliance with required disclosures.
Financial highlights
Q3 total income was 2,880 Mn versus 2,050 Mn; gross profit increased 53% to 963 Mn and gross margin expanded 271 bps to 33.5%.
Q3 EBITDA rose 61.9% to 708 Mn; EBITDA margin increased 325 bps to 24.6%.
Q3 consolidated PBT was Rs 6,918.64 lakh versus Rs 4,206.69 lakh a year earlier.
Q3 PAT margin was 17.28% versus 15.80%; 9M gross margin was 36.2% and EBITDA margin was 23.3%.
Standalone Q3 revenue was Rs 20,415.10 lakh versus Rs 10,400.23 lakh; net profit was Rs 1,829.65 lakh versus Rs 2,794.67 lakh.
Outlook and guidance
Order book stood at 1,750 Mn as of Dec. 31, 2024, and was expected to be executed over the next three to four months; spot e-commerce sales were excluded.
Three additional Mumbai Origem stores were planned for Andheri West, Mulund West and Fairmont Hotel near Mumbai Airport; Delhi-NCR entry was planned after these openings.
Latest events from Goldiam International
- US headwinds pressured revenue, while margins improved and a ₹30 crore Middle-East order expanded reach.526729
Q1 23/24 - Q2 revenue rose 50% as lab-grown jewellery gained share despite margin pressure.526729
Q2 23/24 - Q3 standalone profit rose while consolidated revenue fell versus the prior-year quarter.526729
Q3 23/24 - Lab-grown jewellery reached 49% of FY24 revenue as growth contrasted with lower Q4 audited profit.526729
Q4 23/24 - Q1 income rose as lab-grown jewellery reached 68.4% of export mix.526729
Q1 24/25 - H1 earnings grew as lab-grown mix expanded, while shipment delays and inventory weighed.526729
Q2 24/25 - FY25 earnings grew as lab-grown jewellery reached 82% of Q4 export revenue.526729
Q4 24/25 - Consolidated Q1 profit rose YoY, while standalone profit eased.526729
Q1 25/26 - Record FY26 earnings, 88% lab-grown export mix and a proposed 1-for-3 bonus.526729
Q4 25/26